What is SPECT?
SPECT is a procedure using radioactive isotopes (e.g. technetium-99m labelled molecules) to map blood flow to the brain. The pattern of reduced blood flow can be indicative of certain neurodegenerative diseases, which helps to differentiate between different types of dementia.
DAT-Scan Scan
DAT-Scan (Dopamine transporter scintigraphy) is a special test in which the state of the brain's dopaminergic nerve pathways is examined with a radiolabeled molecule (e.g. I-123 ioflupane). It plays an important role in distinguishing certain types of dementia (e.g. Lewy body dementia, Parkinson's dementia).
Who do we recommend it to?
For those who have a disease causing dementia or increased suspicion of it after using the Diagnostic Package and/or the Genetic Diagnostic Package.
For those who have been diagnosed with dementia or mild cognitive impairment, and would like to receive recommendations for their diagnosis and therapy.
What can happen after the test?
The evaluation of the results obtained takes about 2-3 weeks, based on which the diagnostic and therapeutic recommendation is made as a joint decision of the leading experts of the service (so-called CogniTeamTM). The use of the Differential Diagnostic Services is followed by a personal or online consultation with one of the leading specialists of the service. If no further tests are necessary for an accurate diagnosis, we recommend using our Intervention Services. The examinations can reveal other neurological diseases, in which case we recommend a neurological consultation, which we are happy to help you arrange. In addition, we offer the opportunity to participate in clinical drug trials specific to the given disease, if such a trial is ongoing in the given period.
How to arrive for the examination, and what is the procedure?
You will receive information about the course of each examination on an individual basis.
